Physician profile
Gerald Joseph Gallinghouse
NPI 1497730980
$39,137.17
in general payments reported to CMS, 2019-2025
25 companies · $6,479 in 2025
The $6,479 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,044 · 2020: $5,804 · 2021: $6,395 · 2022: $3,580 · 2023: $8,761 · 2024: $3,074 · 2025: $6,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,792 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,200 · Consulting Fee: $5,100 · Travel and Lodging: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,792.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,200.00 |
| Consulting Fee | $5,100.00 |
| Travel and Lodging | $1,221.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,773.29 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Ensite Precision, Gallant |
| Biosense Webster, INC. | $10,750.82 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic, INC. | $5,274.12 | 2021-2025 | Affera Mapping System |
| Biosig Technologies, INC. | $4,569.53 | 2020-2021 | |
| Atricure, INC. | $2,654.45 | 2019-2024 | |
| Volta Medical INC | $1,097.24 | 2023-2024 | Vx1 |
| Medical Device Business Services, INC. | $1,050.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $652.28 | 2019-2025 | Eliquis, Camzyos |
| Acutus Medical, INC. | $424.03 | 2021-2022 | |
| Boston Scientific Corporation | $415.04 | 2019-2025 | Watchman Flx, Watchman Access System, General - Ep |
| Cardiva Medical, INC. | $284.76 | 2019-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Altathera Pharmaceuticals LLC | $283.70 | 2023-2025 | Sotalol Hydrochloride |
| Novo Nordisk INC | $247.34 | 2022-2025 | Wegovy |
| Edwards Lifesciences Corporation | $124.91 | 2022 | |
| Viz.Ai, INC. | $84.68 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $75.83 | 2023-2025 | Vitalpatch Rtm |
| Johnson & Johnson Health Care Systems INC. | $67.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $63.23 | 2019-2021 | |
| Pfizer INC. | $56.73 | 2022-2025 | |
| Medtronic Vascular, INC. | $55.32 | 2019 | |
| Cvrx, INC. | $52.78 | 2020-2023 | Barostim Neo System |
| Irhythm Technologies, INC. | $37.94 | 2022 | |
| Impulse Dynamics (USA) INC. | $21.09 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.36 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $7.12 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Gallinghouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.